Showing results (121-130 of 135) with videos related to
Sort By:
Pageof 14
Liver Cancer|March 6, 2023
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 TrialZhenggang Ren, Michel Ducreux, Ghassan K Abou-Alfa, et al.The Lancet. Oncology|December 16, 2021
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trialThomas Yau, Joong-Won Park, Richard S Finn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2018
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with <i>RAS</i>-Mutated Hepatocellular CarcinomaHo Yeong Lim, Philippe Merle, Karl Heinz Weiss, et al.Hepatology (Baltimore, Md.)|April 8, 2026
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)Pierre Nahon, Marianne Ziol, Long Pan, et al.Liver Cancer|August 20, 2025
Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational StudyYoon Jun Kim, Philippe Merle, Richard S Finn, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 21, 2020
Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteinsLudivine Kouton, José Boucraut, Jérome Devaux, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2025
Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF CohortManon Allaire, Elhadji Malick Thiam, Guiliana Amaddeo, et al.Plos Neglected Tropical Diseases|April 27, 2018
Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adultsNarcisse Patrice Komas, Sumantra Ghosh, Mariama Abdou-Chekaraou, et al.European Journal of Gastroenterology & Hepatology|August 13, 2025
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapyEric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, et al.European Journal of Neurology|August 1, 2025
Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene-Related Demyelinating Peripheral NeuropathyPauline Jaubert, Camille Loret, Tanya Stojkovic, et al.Pageof 14